These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 26946483)
41. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology. Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296 [TBL] [Abstract][Full Text] [Related]
42. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies. Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491 [TBL] [Abstract][Full Text] [Related]
43. Selective expression of α-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon. Sharrad DF; de Vries E; Brookes SJ J Comp Neurol; 2013 Feb; 521(3):657-76. PubMed ID: 22821666 [TBL] [Abstract][Full Text] [Related]
44. Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies. Brudek T; Winge K; Folke J; Christensen S; Fog K; Pakkenberg B; Pedersen LØ Mol Neurodegener; 2017 Jun; 12(1):44. PubMed ID: 28592329 [TBL] [Abstract][Full Text] [Related]
45. Active immunization therapies for Parkinson's disease and multiple system atrophy. Schneeberger A; Tierney L; Mandler M Mov Disord; 2016 Feb; 31(2):214-24. PubMed ID: 26260853 [TBL] [Abstract][Full Text] [Related]
46. Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies. Barkhordarian H; Emadi S; Schulz P; Sierks MR Protein Eng Des Sel; 2006 Nov; 19(11):497-502. PubMed ID: 16984950 [TBL] [Abstract][Full Text] [Related]
47. α-synuclein in the inner retina in parkinson disease. Bodis-Wollner I; Kozlowski PB; Glazman S; Miri S Ann Neurol; 2014 Jun; 75(6):964-6. PubMed ID: 24816946 [TBL] [Abstract][Full Text] [Related]
48. Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast. Popova B; Kleinknecht A; Braus GH Biomolecules; 2015 Apr; 5(2):617-34. PubMed ID: 25915624 [TBL] [Abstract][Full Text] [Related]
49. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein? Pozo Devoto VM; Falzone TL Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016 [TBL] [Abstract][Full Text] [Related]
50. Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies. Herrmann Y; Bujnicki T; Zafiu C; Kulawik A; Kühbach K; Peters L; Fabig J; Willbold J; Bannach O; Willbold D Clin Chim Acta; 2017 Mar; 466():152-159. PubMed ID: 28088342 [TBL] [Abstract][Full Text] [Related]
51. Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles. Yang SY; Chiu MJ; Lin CH; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH J Nanobiotechnology; 2016 Jun; 14(1):41. PubMed ID: 27278241 [TBL] [Abstract][Full Text] [Related]
52. Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease. Ulusoy A; Decressac M; Kirik D; Björklund A Prog Brain Res; 2010; 184():89-111. PubMed ID: 20887871 [TBL] [Abstract][Full Text] [Related]
57. Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models. Su X; Fischer DL; Li X; Bankiewicz K; Sortwell CE; Federoff HJ Mol Ther; 2017 Oct; 25(10):2231-2235. PubMed ID: 28522034 [No Abstract] [Full Text] [Related]
58. Identification of human alpha-synuclein specific single chain antibodies. Maguire-Zeiss KA; Wang CI; Yehling E; Sullivan MA; Short DW; Su X; Gouzer G; Henricksen LA; Wuertzer CA; Federoff HJ Biochem Biophys Res Commun; 2006 Nov; 349(4):1198-205. PubMed ID: 16973126 [TBL] [Abstract][Full Text] [Related]
59. [Study on exons 3 and 4 of alpha-synuclein gene in Chinese familial Parkinson disease patients]. Chen X; Liu YT; Li JR; Chen L; Xu YM; Pan YH; Meng XH; Xing SH Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):536-8. PubMed ID: 14669226 [TBL] [Abstract][Full Text] [Related]
60. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models. Eschbach J; Danzer KM Neurodegener Dis; 2014; 14(1):1-17. PubMed ID: 24080741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]